Current Ratio of Nuo Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Nuo Therapeutics, Inc. quarterly Current Ratio in x history and change rate from 31 Dec 2010 to 31 Dec 2025.
- Nuo Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 1.06x, a 27% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Nuo Therapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 1.06x | -0.4x | -27% | 31 Dec 2025 |
| Q3 2025 | 1.16x | -0.72x | -38% | 30 Sep 2025 |
| Q2 2025 | 0.85x | -0.85x | -50% | 30 Jun 2025 |
| Q1 2025 | 0.47x | -0.82x | -64% | 31 Mar 2025 |
| Q4 2024 | 1.45x | -0.86x | -37% | 31 Dec 2024 |
| Q3 2024 | 1.88x | +0.04x | +2.4% | 30 Sep 2024 |
| Q2 2024 | 1.7x | +0.25x | +17% | 30 Jun 2024 |
| Q1 2024 | 1.29x | -1.53x | -54% | 31 Mar 2024 |
| Q4 2023 | 2.32x | -2.07x | -47% | 31 Dec 2023 |
| Q3 2023 | 1.84x | -6x | -77% | 30 Sep 2023 |
| Q2 2023 | 1.45x | -6.88x | -83% | 30 Jun 2023 |
| Q1 2023 | 2.82x | +0.79x | +39% | 31 Mar 2023 |
| Q4 2022 | 4.39x | +2.21x | +101% | 31 Dec 2022 |
| Q3 2022 | 7.84x | +7.62x | +3416% | 30 Sep 2022 |
| Q2 2022 | 8.33x | +8.1x | +3539% | 30 Jun 2022 |
| Q1 2022 | 2.02x | +1.79x | +757% | 31 Mar 2022 |
| Q4 2021 | 2.18x | +1.94x | +797% | 31 Dec 2021 |
| Q3 2021 | 0.22x | +0.22x | 30 Sep 2021 | |
| Q2 2021 | 0.23x | +0.23x | 30 Jun 2021 | |
| Q1 2021 | 0.24x | +0.22x | +1865% | 31 Mar 2021 |
| Q4 2020 | 0.24x | +0.06x | +30% | 31 Dec 2020 |
| Q3 2020 | 0x | 30 Sep 2020 | ||
| Q2 2020 | 0x* | 30 Jun 2020 | ||
| Q1 2020 | 0.01x | 31 Mar 2020 | ||
| Q4 2019 | 0.19x | -0.63x | -77% | 31 Dec 2019 |
| Q4 2018 | 0.82x | -0.45x | -35% | 31 Dec 2018 |
| Q3 2018 | 0.46x | -1.07x | -70% | 30 Sep 2018 |
| Q2 2018 | 0.6x | +0.11x | +22% | 30 Jun 2018 |
| Q1 2018 | 0.66x | -0.72x | -52% | 31 Mar 2018 |
| Q4 2017 | 1.26x | -1.06x | -46% | 31 Dec 2017 |
| Q3 2017 | 1.52x | -1.76x | -54% | 30 Sep 2017 |
| Q2 2017 | 0.49x | -2.61x | -84% | 30 Jun 2017 |
| Q1 2017 | 1.38x | +0.78x | +131% | 31 Mar 2017 |
| Q4 2016 | 2.33x | +2.26x | +3124% | 31 Dec 2016 |
| Q3 2016 | 3.28x | +2.25x | +217% | 30 Sep 2016 |
| Q2 2016 | 3.09x | +1.46x | +90% | 30 Jun 2016 |
| Q1 2016 | 0.6x | -1.48x | -71% | 31 Mar 2016 |
| Q4 2015 | 0.07x | -2.45x | -97% | 31 Dec 2015 |
| Q3 2015 | 1.04x | -2.66x | -72% | 30 Sep 2015 |
| Q2 2015 | 1.63x | -1.85x | -53% | 30 Jun 2015 |
| Q1 2015 | 2.08x | +0.51x | +32% | 31 Mar 2015 |
| Q4 2014 | 2.52x | +1.58x | +167% | 31 Dec 2014 |
| Q3 2014 | 3.69x | +2.59x | +235% | 30 Sep 2014 |
| Q2 2014 | 3.48x | +1.59x | +84% | 30 Jun 2014 |
| Q1 2014 | 1.57x | -2.07x | -57% | 31 Mar 2014 |
| Q4 2013 | 0.94x | -1.35x | -59% | 31 Dec 2013 |
| Q3 2013 | 1.1x | -1.52x | -58% | 30 Sep 2013 |
| Q2 2013 | 1.89x | -1.98x | -51% | 30 Jun 2013 |
| Q1 2013 | 3.65x | +1.04x | +40% | 31 Mar 2013 |
| Q4 2012 | 2.29x | +0.65x | +39% | 31 Dec 2012 |
| Q3 2012 | 2.62x | +1.77x | +208% | 30 Sep 2012 |
| Q2 2012 | 3.87x | +3.06x | +376% | 30 Jun 2012 |
| Q1 2012 | 2.61x | 31 Mar 2012 | ||
| Q4 2011 | 1.64x | +0.97x | +143% | 31 Dec 2011 |
| Q3 2011 | 0.85x | 30 Sep 2011 | ||
| Q2 2011 | 0.81x | 30 Jun 2011 | ||
| Q4 2010 | 0.68x | 31 Dec 2010 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.